A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Conditions
Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Central Alabama Research, Birmingham, Alabama, United States
Contact: Principal Investigator (Khaleel Ashraf)University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Garima Gupta)Ironwood Cancer and Research Centers, Chandler, Arizona, United States
Contact: Principal Investigator (Neel Dharia)University of Arizona, Tucson, Arizona, United States
Contact: Principal Investigator (Aaron Scott)University of California San Diego, La Jolla, California, United States
Contact: Principal Investigator (Gregory Botta)University of Southern California, Los Angeles, California, United States
Contact: Principal Investigator (Sandra Algaze)PIH Health Whittier Hospital, Whittier, California, United States
Contact: Principal Investigator (Andrew Pham)Christiana Care Health Services, Newark, Delaware, United States
Contact: Principal Investigator (Jamal Misleh)University of Florida, Gainesville, Florida, United States
Contact: Principal Investigator (Thomas George)University of Miami, Miami, Florida, United States
Baptist Health - Miami Cancer Institute, Miami, Florida, United States
Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Olatunji Alese)Hope and Healing Cancer Services, Hinsdale, Illinois, United States
Contact: Principal Investigator (Srilata Gundala)Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Anita Turk)Our Lady of the Lake Physician Group - LSU Health Baton Rouge Oncology, Baton Rouge, Louisiana, United States
Contact: Principal Investigator (Marshall Stagg)Willis Knighton Cancer Center, Shreveport, Louisiana, United States
Contact: Principal Investigator (Joyce Feagin)Mercy Medical Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Panayotis Ledakis)Boston Medical Center, Boston, Massachusetts, United States
Hattiesburg Clinic, Hattiesburg, Mississippi, United States
Contact: Principal Investigator (John Hrom)Saint Luke's Cancer Institute, Kansas City, Missouri, United States
Midwest Oncology Associates - Kansas City, Kansas City, Missouri, United States
Contact: Principal Investigator (Jaswinder Singh)SSM Health St. Louis DePaul Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Brian Smith)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Nikolaos Andreatos)Capital Health Medical Center - Hopewell, Pennington, New Jersey, United States
Contact: Principal Investigator (Hongyan Liang)Columbia University, New York, New York, United States
Albert Einstein College of Medicine, The Bronx, New York, United States
James J Peters Veterans Administration Medical Center - NAVREF, The Bronx, New York, United States
Zangmeister Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Sameh Mikhail)Hightower Clinical Research, Oklahoma City, Oklahoma, United States
Jefferson Health, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Atrayee Basu-Mallick)Fox Chase Cancer Center | Philadelphia, PA, Philadelphia, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
University of Tennessee -- Memphis, Memphis, Tennessee, United States
Contact: Principal Investigator (Saurin Chokshi)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Brooke Looney)University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Nilesh Verma)Renovatio Clinical, El Paso, Texas, United States
Contact: Principal Investigator (Mary Crow)Oncology Consultants - Memorial City Location, Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero)Baylor College of Medicine, Houston, Texas, United States
Contact: Principal Investigator (Karen Riggins)BRCR Global, Katy, Texas, United States
Renovatio Clinical, The Woodlands, Texas, United States
Contact: Principal Investigator (Jonathon Lu)Tranquil Research, Webster, Texas, United States
Contact: Principal Investigator (John Knecht)UC Irvine Medical Center - Chao Family Comprehensive Cancer, Orange, Virginia, United States
Contact: Principal Investigator (Farshid Dayyani)Virginia Commonwealth University, Richmond, Virginia, United States
Contact: Principal Investigator (Khalid Matin)Medstar Speciality Hospital, Northwest, Washington, United States
Contact: Principal Investigator (Marcus Noel)Fundacion de Investigacion de Diego (FDI Clinical Research), San Juan, Puerto Rico
Study leads
Study Director
Takeda